Researchers have come out with a new insulin that can withstand higher temperatures, a development that will bring relief to millions of diabetics across the world.
Normally, insulin starts to go bad above four degrees centigrade - making its supply very difficult in areas that lack refrigeration.
The poor stability of existing forms of insulin complicates the management of diabetes.
They have just filed a series of patents with their partner ASX-listed Circadian Technologies for marketing it.
At the same time, they're using their new knowledge to develop a form of insulin that could be delivered by pill.
"Over 200 million people need insulin to manage diabetes, but we still don't know how it works at a molecular level," says van Lierop, according to a Monash release.
She will be presenting her work at Fresh Science, a national science talent search, at Melbourne Museum.